Skip to main content
SpringerLink
Log in

Free Level Monitoring of Antiepileptic Drugs Clinical Usefulness and Case Studies

  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

The free fraction of phenytoin, carbamazepine and valproic acid shows considerable interindividual variability, especially in the presence of associated disease or drug interactions. When binding is altered, the total concentration no longer reflects the amount of pharmacologically active drug in the plasma: this may mislead the clinician into making inappropriate dosage adjustments. Measuring the free drug concentration eliminates a potential source of interpretative errors and may be preferentially used to monitor therapy in selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Barth, N.; Alvan, G.; Borgå, O. and Sjöqvist, F.: Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy. Clinical Pharmacokinetics 1: 444–452 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Bertilsson, L.: Clinical pharmacokinetics of carbamazepine. Clinical Pharmacokinetics 3: 128–143 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Blum, M.R.; Riegelman, S. and Becker, C.E.: Altered protein binding of diphenylhydantoin in uremic plasma. New England Journal of Medicine 286: 109 (1972).

    PubMed  CAS  Google Scholar 

  • Booker, H.E. and Darcey, B.: Serum concentrations of free diphenylhydantoin and their relationship to clinical intoxication. Epiiepsia 14: 177–184 (1973).

    Article  CAS  Google Scholar 

  • Boston Collaborative Drug Surveillance Program: Diphenylhydantoin side effects and serum albumin levels. Clinical Pharmacology and Therapeutics 14: 529–532 (1973).

    Google Scholar 

  • Bowdle, T.A.; Patel, I.H.; Levy, R.H. and Wilensky, A.J.: Val-proic acid dosage and plasma protein binding and clearance. Clinical Pharmacology and Therapeutics 28: 486–492 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Bruni, J.; Gallo, J.M.; Lee, C.S.; Perchalski, R.J. and Wilder, B.J.: Interactions of valproic acid with phenytoin. Neurology 30: 1233–1236 (1980a).

    Article  PubMed  CAS  Google Scholar 

  • Bruni, J.; Wang, L.H.; Marbury, T.C.; Lee, C.S. and Wilder, B.J.: Protein binding of valproic acid in uraemic patients. Neurology 30: 557–559 (1980b).

    Article  PubMed  CAS  Google Scholar 

  • Burgess, E.D.; Friel, P.N.; Blair, A.D. and Raisy, V.A.: Serum phenytoin concentrations in uremia. Annals of Internal Medicine 94: 59–60 (1981).

    PubMed  CAS  Google Scholar 

  • Cramer, J.A. and Mattson, R.H.: Valproic acid: In vitro plasma protein binding and interaction with phenytoin. Therapeutic Drug Monitoring 1: 105–116 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Green, P.J.; Vlasses, P.H.; Frauenhoffer, S.M. and Hennessey, K.M.: Phenytoin can be measured reliably in uremic patients by immunoassay. Clinical Chemistry 29: 737 (1983).

    PubMed  CAS  Google Scholar 

  • Gugler, R. and Mueller, G.: Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease. British Journal of Clinical Pharmacology 5: 441–446 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Hoppener, R.J.; Kuyer, A.; Meijer, J.W.A. and Hulsman, J.: Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects. Epilepsia 21: 341–350 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Klotz, U.; Rapp, T. and Mueller, W.A.: Disposition of valproic acid in patients with liver disease. European Journal of Clinical Pharmacology 13: 55–60 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Levy, R.H.: Monitoring of free valproic acid levels? Therapeutic Drug Monitoring 2: 199–201 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Levy, R.H. and Koch, K.M.: Drug interactions with valproic acid. Drugs 24: 543–556 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Loiseau, P.: Sodium valproate, platelet dysfunction and bleeding. Epilepsia 22: 141–146 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Mattson, R.H.; Cramer, J.A.; Williamson, P.O. and Novelly, R.A.: Valproic acid in epilepsy: Clinical and pharmacological effects. Annals of Neurology 3: 20–25 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Mattson, G.F.; Mattson, R.H. and Cramer, J.A.: Interaction between valproic acid and carbamazepine: An in vitro study of protein binding. Therapeutic Drug Monitoring 4: 181–184 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Murphy, J.U. and Marquardt, K.: Asymptomatic hyperammoniemia in patients receiving valproic acid. Annals of Neurology 39: 591–592 (1982).

    Article  CAS  Google Scholar 

  • Nandedkar, A.; Williamson, R.; Kutt, H. and Fairclough, G.F.: A comparison of plasma phenytoin level determinations by EMIT and gas-liquid chromatography in patients with renal insufficiency. Therapeutic Drug Monitoring 2: 427–430 (1980).

    PubMed  CAS  Google Scholar 

  • Neuvonen, P.J.; Lehtovaara, R.; Bardy, A. and Elomaa, E.E.: Antiepileptic analgesics in patients on antiepileptic drug therapy. European Journal of Clinical Pharmacology 15: 263–268 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Odar-Cederlöf, I.; Lunde, P. and Sjöqvist, F.: Abnormal pharmacokinetics of phenytoin in a patient with uraemia. Lancet 2: 831–832 (1970).

    Article  PubMed  Google Scholar 

  • Patel, I.H. and Levy, R.H.: Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsants and free fatty acids. Epilepsia 20: 85–90 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Perucca, E.: Plasma protein binding of phenytoin in health and disease: Relevance to therapeutic drug monitoring. Therapeutic Drug Monitoring 2: 331–344 (1980).

    PubMed  CAS  Google Scholar 

  • Perucca, E.: Pharmacokinetic interactions with antiepileptic drugs. Clinical Pharmacokinetics 7: 57–84 (1982a).

    Article  PubMed  CAS  Google Scholar 

  • Perucca, E.: Anticonvulsant drug interactions; in Sandier (Ed.) Psychopharmacology of Anticonvulsants, pp. 122–128 (Oxford University Press, Oxford, New York, Toronto 1982b).

    Google Scholar 

  • Perucca, E.; Grimaldi, R.; Gatti, G.; Lecchini, S.; Frigo, G.M. and Crema, A.: Pharmacokinetics of valproic acid in young and elderly subjects. British Journal of Clinical Pharmacology (Submitted for publication, 1983).

  • Perucca, E.; Hebdige, S.; Gatti, G.; Lecchini, S.; Frigo, G.M. and Crema, A.: Interaction between phenytoin and valproic acid: Plasma protein binding and metabolic effects. Clinical Pharmacology and Therapeutics 28: 779–789 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Perucca, E. and Richens, A.: Interpretation of drug els: Relevance of plasma protein binding; in Drug Concentrations in Neuro-psychiatry, pp. 51–68 (Excerpta Medica, Amsterdam 1980).

    Google Scholar 

  • Perucca, E.; Ruprah, M. and Richens, A.: Altered drug binding to serum proteins in pregnant women: Therapeutic relevance. Journal of the Royal Society of Medicine 74: 422–426 (1981).

    PubMed  CAS  Google Scholar 

  • Porter, R.J. and Layzer, R.B.: Plasma albumin concentration and diphenylhydantoin binding in man. Archives of Neurology (Chicago) 32: 298–303 (1975).

    Article  CAS  Google Scholar 

  • Reidenberg, M.M. and Affrime, M.: Influence of disease on binding of drugs to plasma proteins. Annals of the New York Academy of Sciences 226: 115–126 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Reidenberg, M.M.; Odar-Cederlöf, I.; von Bahr, C; Borgå, O. and Sjöqvist, F.: Protein binding of DPH and desmethyl-imipra-mine in plasma from patients with poor renal function. New England Journal of Medicine 285: 264–267 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Riva, R.; Albani, A.; Baruzzi, A.; Galvani, I. and Perucca, E.: Determination of unbound valproic acid concentration in plasma by equilibrium dialysis and gas-liquid chromatography: Methodological aspects and observations in epileptic patients. Therapeutic Drug Monitoring 4: 341–352 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Riva, R.; Albani, F.; Cortelli, P.; Gobbi, G.; Perucca, E. and Baruzzi, A.: Diurnal fluctuations in free and total plasma concentrations of valproic acid at steady-state in epileptic patients. Therapeutic Drug Monitoring 5: 191–196 (1983a).

    Article  PubMed  CAS  Google Scholar 

  • Riva, R.; Albani, F.; Franzoni, A.; Perucca, E.; Santucci, M. and Baruzzi, A.: Valproic acid free fraction in epileptic children under chronic monotherapy. Therapeutic Drug Monitoring 5: 197–200 (1983b).

    Article  PubMed  CAS  Google Scholar 

  • Riva, R.; Albani, F.; Ambrosetto, G.; Contin, M.; Cortelli, P.; Perucca, E. and Baruzzi, A.: Diurnal fluctuations in free and total plasma concentrations of carbamazepine at steady-state and correlation with intermittent side effects in epileptic patients. Journal of Neurology, Neurosurgery and Psychiatry (Submitted for publication, 1983c).

  • Rodin, E.A.; De Sousa, G.; Haydukewych, D.; Lodhi, R. and Berchou, R.C.: Dissociation between free and bound phenytoin levels in presence of valproate sodium. Archives of Neurology 38: 240–242 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Wheeler, S.D.; Ramsay, R.E. and Weiss, J.: Drug-induced downbeat nystagmus. Annals of Neurology 12: 227–228 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Willmore, L.J.; Wilder, B.J.; Bruni, J. and Villareal, H.J.: Effect of valproic acid on hepatic function. Neurology 28: 961–964 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Zaccara, G.; Paganini, M.; Campostrini, R.; Arnetoli, G.; Zappoli, R. and Moroni, F.: Hyperammoniemia and valproate-in-duced alterations of the state of consciousness. Epilepsia (In press, 1983).

Download references

Author information

Authors and Affiliations

  1. Clinical Pharmacology Unit, Institute of Medical Pharmacology, University of Pavia, Piazza Botta 10, 27100, Pavia, Italy

    E. Perucca

Authors
  1. E. Perucca
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perucca, E. Free Level Monitoring of Antiepileptic Drugs Clinical Usefulness and Case Studies. Clin Pharmacokinet 9 (Suppl 1), 71–78 (1984). https://doi.org/10.2165/00003088-198400091-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198400091-00009

Keywords

Search

Navigation